한국어
English
日本語
中文(简体)
Revolade 25 mg Tablets (Eltrombopag)
31.9mg
Tablet · Prescription medication
Korea Novartis Co., Ltd.
Eltrombopag olamine is an ingredient that promotes platelet production and is used to treat thrombocytopenia.
MFDS ingredient code M249549
Eltrombopag olamine is a platelet production promoter, used to increase platelet counts in patients with thrombocytopenia. This helps restore platelet levels in the blood to normal and reduce the risk of bleeding.
This ingredient binds to receptors involved in platelet production in the bone marrow, stimulating the production of platelets. This results in an increase in platelet counts and improves blood coagulation function.
Approved uses differ by product. Check each product's information for its actual use.
Unlike conventional platelet production promoters, eltrombopag olamine can be administered orally and selectively acts on specific receptors to effectively increase platelet production.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
4 total
31.9mg
Tablet · Prescription medication
Korea Novartis Co., Ltd.
63.8mg
Tablet · Prescription medication
Korea Novartis Co., Ltd.
31.9mg
Tablet · Prescription medication
Korea Pharma Bio Co., Ltd.
63.8mg
Tablet · Prescription medication
Korea Pharma Bio Co., Ltd.
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
Product approval information is based on drug information provided by the Ministry of Food and Drug Safety.
Ingredient and class descriptions are not part of MFDS data and were written separately by Cashdoc.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.